COVID-19 – Where Does The Pharmaceutical Industry Go From Here?
Shots: The approval is based on ENSEMBLE PLUS study, which demonstrated comparable frequency and severity of IRRs for 2hrs. OCREVUS infusion time (dosed twice yearly) vs conventional 3.5hrs in patients with RRMS. The initial dose is given as two 300mg infusions given 2wks. apart and a subsequent dose single 600mg infusions were administered over a […]Read More
